ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 294979 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 294979; 2) Community: the network communities that were significantly associated with the response to NSC 294979; 3) Molecule: the relationships between components within communities and NSC 294979; 4) MDR: the compounds that were significantly associated with the NSC 294979.

NSC Compound Enrichment Correlation
NSC 690116 Null 0.0115521552688255 -0.093883281
NSC 733164 Null 0.0115521552688255 -0.10741874
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0115521552688255 -0.21251511
NSC 757981 Null 0.0115521552688255 0.010829383
NSC 734148 2-(4-Chloro-benzenesulfonylimino)-imidazolidine-1-carbodithi oic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4] thiadiazol-7-yl ester 0.0115521552688257 0.047038147
NSC 201863 N-[1-(Biphenyl-4-yl)ethyl]-3,4-dichlorobenzamide 0.0115521552688258 0.29466164
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0115521552688258 0.1178538
NSC 669995 Null 0.0137568419586475 -0.18145223
NSC 670678 Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester 0.0137568419586475 0.24328109
NSC 763582 Null 0.0137568419586475 0.41481829
Total:90  Current:29    [First] [Prev] [Next] [Last]